Substituted azole compound and antidiabetes agent
To provide a novel substituted azole compound having a GPR119-activating activity and useful particularly for the prevention and/or treatment of diabetes and obesity. Provided are: a novel substituted azole compound represented by formula (I) (wherein each substituent is as defined in detail in the...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
16.07.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | To provide a novel substituted azole compound having a GPR119-activating activity and useful particularly for the prevention and/or treatment of diabetes and obesity. Provided are: a novel substituted azole compound represented by formula (I) (wherein each substituent is as defined in detail in the description; the ring A represents an aromatic ring which may be substituted by a substituent as defined in the description; the ring B represents a ring selected from rings represented by formula (II); R1 represents a hydrogen atom, an alkyl group or the like; R2 represents an alkyl group or the like; the ring C represents a benzene ring, a 5- to 6-membered aromatic heterocyclic ring or the like; and R3 and R4 independently represent an alkyl group which may be substituted or the like), a tautomer or pharmaceutically acceptable salt of the compound, or a solvate of the compound or the tautomer or pharmaceutically acceptable salt. |
---|---|
Bibliography: | Application Number: TW20150115166 |